CTOs on the Move

Daily.co

www.daily.co

 
Hello! We`re Daily, the developer platform for real-time video. Our APIs let developers add video calls to any app or site.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.daily.co
  • 1231 9th Ave
    San Francisco, CA USA 94116
  • Phone: N/A

Executives

Name Title Contact Details

Funding

Daily.co raised $15M on 03/09/2021
Daily.co raised $40M on 11/10/2021

Similar Companies

Eagle Technology

Eagle Technology has been a leader in development and sale of Computerized Maintenance Management Systems (CMMS) software and Enterprise Asset Management (EAM) solutions since 1986. With over 3000 users in 34 countries, Eagle has developed partnerships with companies such as: Johnson Controls, Honeywell, Delta Controls, Trane, and Tridium to promote, manage and service its customers worldwide. Our CMMS products are a favorite among entities like Johnson Controls, Honeywell and Siemens as well as smaller organizations because we understand that no two companies have the same demands or expectations. We have a proven history of offering Proteus CMMS to companies in order to help them reduce downtime and keep their production schedule running smoothly while also keeping machines and tools in the best possible working order by running routine maintenance on time. Proteus CMMS helps clients collect the Big Data that results from running a complex manufacturing operation and distill it down into understandable reports that give companies all the information they need to make the right decisions for ongoing efficiency and profitability.

Learn on Demand Systems

"Excellent Option to Deliver a Virtual Lab Experience"

boldstart ventures

First check for bold founders reinventing the enterprise stack. Lead investor and partnering with Fortune 500 CIOs, CTOs, CISOs to accelerate time to market.

Immunome

Immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. Our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. This proprietary technology platform enables the simultaneous discovery of novel antigens and the patient-derived, native antibodies that target those antigens. We then employ a battery of high-content screening technologies to identify specific and high-affinity antibodies that offer significant therapeutic potential to change the way we treat cancer.

AIKON

Blockchain and crypto are technologically complex. AIKON makes it simple. We`ve built a suite of intuitive products built on the ORE Network ($ORE) for enterprise companies looking to provide a seamless user experience that works cross-chain with Algorand, Ethereum, EOS and more.